FDA's Drug Watchlist

US Food and Durg Administration has released its 20 drugs watchlist:

1. Arginine Hydrochloride Injection (R-Gene 10) - Pediatric overdose due to labeling / packaging confusion
2. Desflurane (Suprane) - Cardiac arrest (heart stops working)
3. Duloxetine (Cymbalta) - Urinary retention
4. Etravirine (Intelence) - Hemarthrosis (blood in a joint)
5. Fluorouracil Cream (Carac) and Ketoconazole Cream (Kuric) - Adverse events due to name confusion
6. Heparin - Anaphylactic-type (life-threatening allergic) reactions
7. Icodextrin (Extraneal) - Hypoglycemia (low blood sugar)
8. Insulin U-500 (Humulin R) - Dosing confusion
9. Ivermectin (Stromectol) and Warfarin - Drug interaction
10 Lapatinib (Tykerb) - Hepatotoxicity (liver toxicity)
11. Lenalidomide (Revlimid) - Stevens-Johnson syndrome (a deadly drug reaction)
12. NataliNitroglycerin - Skin melanomas (deadly skin cancer)
13. Nitroglycerin (Nitrostat) - Overdose due to labeling confusion
14. Octreotide Acetate Depot (Sandostatin LAR) - Ileus (bowels not moving)
15. Oxycodone Hydrochloride Controlled-Release (OxyContin) - Drug misuse, abuse, and overdose
16. Perflutren Lipid Microsphere (Definity) - Cardiopulmonary reactions (lung/heart problems)
17. Phenytoin Injection (Dilantin) - Purple glove syndrome (discoloration, pain, and swelling of the hand that may lead to amputation)
18. Quetiapine (Seroquel) - Overdose due to sample pack labeling confusion
19. Tebivudine (Tyzeka) - Peripheral neuropathy (tingling or numbness in the extremities)
20. Tumor Necrosis Factor (TNF) Blockers - Cancers in children and young adults

"This extends our commitment to keep the public and the health care community informed of what we are evaluating," Paul Seligman, MD, MPH, FDA associate director of safety policy and communication, said at the news conference

Click here to read the article